Capecitabine
- Product NDC
- 0093-7473
- 11-digit product format
- 000937473
- Labeler code
- 0093
- Product ID
- 0093-7473_94cd2146-70ff-43e3-a896-b9e55d75540f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Capecitabine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA091649
- Marketing category
- ANDA
- Marketing start
- 2014-03-07
- Substance
- CAPECITABINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Capecitabine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CAPECITABINE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6804DJ8Z9U |
| Rxcui | 200327, 200328 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-7473-06 | Capecitabine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-7473 | CAPECITABINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] | 13 | Current NDC, Legacy NDC, 1 package rows | 20240815_5753679a-506c-4ac4-b8b2-b27c664d1d40.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-7473-06 | 00093747306 | 60 TABLET, FILM COATED in 1 BOTTLE (0093-7473-06) | 2014-03-07 | 0000-00-00 | No | No | Current |